BIOMAT Database Logo BIOMAT Database Logo

Permanent expression of human CD59 and/or decay-accelerating factor by rat endothelial cells confers protection from human complement-mediated lysis. 1995

B Charreau, and A Cassard, and L Tesson, and B Le Mauff, and D Blanchard, and D Lublin, and J P Soulillou, and I Anegon
Institut National de la Santé et de la Recherche Médicale (INSERM U211), Nantes, France.

UI MeSH Term Description Entries
D008562 Membrane Glycoproteins Glycoproteins found on the membrane or surface of cells. Cell Surface Glycoproteins,Surface Glycoproteins,Cell Surface Glycoprotein,Membrane Glycoprotein,Surface Glycoprotein,Glycoprotein, Cell Surface,Glycoprotein, Membrane,Glycoprotein, Surface,Glycoproteins, Cell Surface,Glycoproteins, Membrane,Glycoproteins, Surface,Surface Glycoprotein, Cell,Surface Glycoproteins, Cell
D011994 Recombinant Proteins Proteins prepared by recombinant DNA technology. Biosynthetic Protein,Biosynthetic Proteins,DNA Recombinant Proteins,Recombinant Protein,Proteins, Biosynthetic,Proteins, Recombinant DNA,DNA Proteins, Recombinant,Protein, Biosynthetic,Protein, Recombinant,Proteins, DNA Recombinant,Proteins, Recombinant,Recombinant DNA Proteins,Recombinant Proteins, DNA
D002470 Cell Survival The span of viability of a cell characterized by the capacity to perform certain functions such as metabolism, growth, reproduction, some form of responsiveness, and adaptability. Cell Viability,Cell Viabilities,Survival, Cell,Viabilities, Cell,Viability, Cell
D003165 Complement System Proteins Serum glycoproteins participating in the host defense mechanism of COMPLEMENT ACTIVATION that creates the COMPLEMENT MEMBRANE ATTACK COMPLEX. Included are glycoproteins in the various pathways of complement activation (CLASSICAL COMPLEMENT PATHWAY; ALTERNATIVE COMPLEMENT PATHWAY; and LECTIN COMPLEMENT PATHWAY). Complement Proteins,Complement,Complement Protein,Hemolytic Complement,Complement, Hemolytic,Protein, Complement,Proteins, Complement,Proteins, Complement System
D003169 Complement Inactivator Proteins Serum proteins that negatively regulate the cascade process of COMPLEMENT ACTIVATION. Uncontrolled complement activation and resulting cell lysis is potentially dangerous for the host. The complement system is tightly regulated by inactivators that accelerate the decay of intermediates and certain cell surface receptors. Complement Cytolysis Inhibiting Proteins,Complement Cytolysis Inhibitor Proteins,Complement Inactivating Proteins,Serum Complement Inactivators,Complement Inactivators, Serum,Inactivating Proteins, Complement,Inactivator Proteins, Complement,Inactivators, Serum Complement,Proteins, Complement Inactivating,Proteins, Complement Inactivator
D004730 Endothelium, Vascular Single pavement layer of cells which line the luminal surface of the entire vascular system and regulate the transport of macromolecules and blood components. Capillary Endothelium,Vascular Endothelium,Capillary Endotheliums,Endothelium, Capillary,Endotheliums, Capillary,Endotheliums, Vascular,Vascular Endotheliums
D005434 Flow Cytometry Technique using an instrument system for making, processing, and displaying one or more measurements on individual cells obtained from a cell suspension. Cells are usually stained with one or more fluorescent dyes specific to cell components of interest, e.g., DNA, and fluorescence of each cell is measured as it rapidly transverses the excitation beam (laser or mercury arc lamp). Fluorescence provides a quantitative measure of various biochemical and biophysical properties of the cell, as well as a basis for cell sorting. Other measurable optical parameters include light absorption and light scattering, the latter being applicable to the measurement of cell size, shape, density, granularity, and stain uptake. Cytofluorometry, Flow,Cytometry, Flow,Flow Microfluorimetry,Fluorescence-Activated Cell Sorting,Microfluorometry, Flow,Cell Sorting, Fluorescence-Activated,Cell Sortings, Fluorescence-Activated,Cytofluorometries, Flow,Cytometries, Flow,Flow Cytofluorometries,Flow Cytofluorometry,Flow Cytometries,Flow Microfluorometries,Flow Microfluorometry,Fluorescence Activated Cell Sorting,Fluorescence-Activated Cell Sortings,Microfluorimetry, Flow,Microfluorometries, Flow,Sorting, Fluorescence-Activated Cell,Sortings, Fluorescence-Activated Cell
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D001011 Aorta The main trunk of the systemic arteries. Aortas

Related Publications

B Charreau, and A Cassard, and L Tesson, and B Le Mauff, and D Blanchard, and D Lublin, and J P Soulillou, and I Anegon
Relative roles of decay-accelerating factor, membrane cofactor protein, and CD59 in the protection of human endothelial cells against complement-mediated lysis.
December 1992, European journal of immunology,
B Charreau, and A Cassard, and L Tesson, and B Le Mauff, and D Blanchard, and D Lublin, and J P Soulillou, and I Anegon
Protection of mammalian cells from complement-mediated lysis by transfection of human membrane cofactor protein and decay-accelerating factor.
January 1991, Transactions of the Association of American Physicians,
B Charreau, and A Cassard, and L Tesson, and B Le Mauff, and D Blanchard, and D Lublin, and J P Soulillou, and I Anegon
Protection of human breast cancer cells from complement-mediated lysis by expression of heterologous CD59.
January 1999, Clinical and experimental immunology,
B Charreau, and A Cassard, and L Tesson, and B Le Mauff, and D Blanchard, and D Lublin, and J P Soulillou, and I Anegon
Surface expression of complement regulatory proteins, decay-accelerating factor (DAF) and CD59, on cultured human endothelial cells.
December 1998, Fukushima journal of medical science,
B Charreau, and A Cassard, and L Tesson, and B Le Mauff, and D Blanchard, and D Lublin, and J P Soulillou, and I Anegon
Protection of porcine aortic endothelial cells from complement-mediated cell lysis and activation by recombinant human CD59.
May 1994, Transplantation,
B Charreau, and A Cassard, and L Tesson, and B Le Mauff, and D Blanchard, and D Lublin, and J P Soulillou, and I Anegon
Protection of xenogeneic cells from human complement-mediated lysis by the expression of human DAF, CD59 and MCP.
October 2001, FEMS immunology and medical microbiology,
B Charreau, and A Cassard, and L Tesson, and B Le Mauff, and D Blanchard, and D Lublin, and J P Soulillou, and I Anegon
Expression of human decay accelerating factor or membrane cofactor protein genes on mouse cells inhibits lysis by human complement.
January 1992, Transplant international : official journal of the European Society for Organ Transplantation,
B Charreau, and A Cassard, and L Tesson, and B Le Mauff, and D Blanchard, and D Lublin, and J P Soulillou, and I Anegon
Expression of human decay accelerating factor or membrane cofactor protein genes on mouse cells inhibits lysis by human complement.
April 1992, Transplantation proceedings,
B Charreau, and A Cassard, and L Tesson, and B Le Mauff, and D Blanchard, and D Lublin, and J P Soulillou, and I Anegon
Decay-accelerating factor confers protection against complement-mediated podocyte injury in acute nephrotoxic nephritis.
May 2002, Laboratory investigation; a journal of technical methods and pathology,
B Charreau, and A Cassard, and L Tesson, and B Le Mauff, and D Blanchard, and D Lublin, and J P Soulillou, and I Anegon
Combination of decay-accelerating factor expression and alpha1,3-galactosyltransferase knockout affords added protection from human complement-mediated injury.
September 1997, Transplantation,
Copied contents to your clipboard!